Fig. 4 (abstract P179).From: 32nd Annual Meeting and Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2017): Part OneIL-12 plus doxorubicin enhanced the accumulation of NKG2D+CD8+ T cells, and reduced the infiltration of Treg cells in tumorsBack to article page